Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Censoring Survival Data01:09

Censoring Survival Data

486
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
486
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

356
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
356
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

524
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
524
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

362
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
362
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

514
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
514
Accuracy and Errors in Hypothesis Testing01:13

Accuracy and Errors in Hypothesis Testing

533
Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
533

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-driven Abdominal Aortic Calcification Extracted From Contrast-enhanced CT Is Predictive of All-cause Mortality and Cardiovascular Events in a Large Adult Population.

Journal of computer assisted tomography·2026
Same author

Causal Inference for First Non-Fatal Events With the Competing Risk of Death: A Principal Stratification Approach.

Statistics in medicine·2025
Same author

Automated abdominal CT imaging biomarkers and clinical frailty measures associated with postoperative deceased-donor liver transplant outcomes.

European radiology·2025
Same author

Biological age model using explainable automated CT-based cardiometabolic biomarkers for phenotypic prediction of longevity.

Nature communications·2025
Same author

Image-guided percutaneous mesenteric biopsy: diagnostic yield and safety profile.

Abdominal radiology (New York)·2024
Same author

AI-based abdominal CT measurements of orthotopic and ectopic fat predict mortality and cardiometabolic disease risk in adults.

European radiology·2024

Related Experiment Video

Updated: Jan 3, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Missing data and sensitivity analysis for binary data with implications for sample size and power of randomized

Thomas Cook1, Ryan Zea1

  • 1Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, Wisconsin.

Statistics in Medicine
|November 15, 2019
PubMed
Summary

Missing data in clinical trials can mislead results, especially with larger sample sizes. Adjusting sample sizes for missing data is crucial, often requiring significantly larger increases than traditionally assumed.

Keywords:
missing datapowerrandomized controlled trialsample sizesensitivity analysis

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K

Related Experiment Videos

Last Updated: Jan 3, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.9K

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Statistical Analysis

Background:

  • Missing outcomes are frequent in randomized controlled clinical trials.
  • Further research is needed on the impact of missing data on trial power and acceptable missingness rates.

Purpose of the Study:

  • To demonstrate the misleading nature of complete-case analyses in clinical trials.
  • To assess the impact of missing data rates and sample sizes on study conclusions.
  • To provide methods for sensitivity analysis and sample size adjustment for missing data.

Main Methods:

  • Illustrative analysis using binary responses.
  • Application of principled sensitivity analysis to assess robustness.
  • Sample size adjustment calculations accounting for expected missingness.

Main Results:

  • Complete-case analyses can yield seriously misleading conclusions.
  • The adverse impact of missing data intensifies with higher missingness rates and larger sample sizes.
  • Sensitivity analysis reveals dramatically larger sample size adjustments are needed than traditional methods suggest.

Conclusions:

  • Missing data significantly compromises the validity of clinical trial conclusions.
  • Principled sensitivity analysis is essential for robust trial interpretation.
  • Achieving desired power can be impossible in large trials with small effect sizes when accounting for missing data.